DNA Repair Gene XRCC1 Polymorphisms and Head and Neck Cancer Risk: An Updated Meta-Analysis Including 16344 Subjects

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Lou, Yin ^a   Peng, Wen jia ^a   Cao, Dong sheng ^a   Xie, Juan ^a   Li, Hong hong ^a   Jiang, Zheng xuan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; HISTIDINE; TRYPTOPHAN; XRCC1 PROTEIN; DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HEAD AND NECK CANCER; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MOUTH CANCER; NASOPHARYNX CANCER; OROPHARYNX CANCER; PHARYNX CANCER; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; SYSTEMATIC REVIEW; TONGUE CANCER; TUMOR LOCALIZATION; XRCC1 GENE; DNA REPAIR; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; META ANALYSIS;

DNA REPAIR; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; POLYMORPHISM, GENETIC;

EID: 84884511217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074059     Document Type: Article

References (57)

1. Marcu LG, Yeoh E, (2009) A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. J Cancer Res Clin Oncol 135: 1303-1314. doi:10.1007/s00432-009-0648-7. PubMed: 19641938.
2. Kamangar F, Dores GM, Anderson WF, (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150. doi:10.1200/JCO.2005.05.2308. PubMed: 16682732.
3. Parkin DM, Pisani P, Ferlay J, (1999) Global cancer statistics. CA Cancer J Clin 49: 33-64. doi:10.3322/canjclin.49.1.33. PubMed: 10200776.
4. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, et al. (2004) Cancer statistics, 2004. CA Cancer J Clin 54: 8-29. doi:10.3322/canjclin.54.1.8. PubMed: 14974761.
5. Hiyama T, Sato T, Yoshino K, Tsukuma H, Hanai A, et al. (1992) Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res 83: 334-339. doi:10.1111/j.1349-7006.1992.tb00111.x. PubMed: 1506266.
6. Geisler SA, Olshan AF, (2001) GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 154: 95-105. doi:10.1093/aje/154.2.95. PubMed: 11447041.
7. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, et al. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21: 7435-7451. doi:10.1038/sj.onc.1205803. PubMed: 12379884.
8. Zhong Y, Carmella SG, Upadhyaya P, Hochalter JB, Rauch D, et al. (2011) Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem Res Toxicol 24: 246-252. doi:10.1021/tx100345x. PubMed: 21184614.
9. Hoeijmakers JH, (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374. doi:10.1038/35077232. PubMed: 11357144.
10. Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, et al. (2004) DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev 28: 194-199. PubMed: 15225899.
11. Csejtei A, Tibold A, Koltai K, Varga Z, Szanyi I, et al. (2009) Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Anticancer Res 29: 4169-4173. PubMed: 19846968.
12. Laantri N, Jalbout M, Khyatti M, Ayoub WB, Dahmoul S, et al. (2011) XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Mol Carcinog 50: 732-737. doi:10.1002/mc.20754. PubMed: 21520294.
13. Ramachandran S, Ramadas K, Hariharan R, Rejnish Kumar R, Radhakrishna Pillai M, (2006) Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 42: 350-362. PubMed: 16324877.
14. Olshan AF, Watson MA, Weissler MC, Bell DA, (2002) XRCC1 polymorphisms and head and neck cancer. Cancer Lett 178: 181-186. PubMed: 11867203.
15. Kumar A, Pant MC, Singh HS, Khandelwal S, (2012) Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population. Mutat Res 729: 24-34. doi:10.1016/j.mrfmmm.2011.09.001. PubMed: 21945240.
16. Flores-Obando RE, Gollin SM, Ragin CC, (2010) Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers 15: 379-399. doi:10.3109/13547501003797664. PubMed: 20429839.
17. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-102. doi:10.2307/3001666.
18. Higgins JP, Thompson SE, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. doi:10.1002/sim.1186. PubMed: 12111919.
19. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
20. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748. PubMed: 13655060.
21. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. doi:10.2307/2533446. PubMed: 7786990.
22. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563.
23. Gal TJ, Huang WY, Chen C, Hayes RB, Schwartz SM, (2005) DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope 115: 2221-2231. doi:10.1097/01.mlg.0000183736.96004.f7. PubMed: 16369171.
24. Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, et al. (2011) Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol 99: 356-361. doi:10.1016/S0167-8140(11)71051-9. PubMed: 21704413.
25. Yang CH, Chuang LY, Cheng YH, Lin YD, Wang CL, et al. (2012) Single nucleotide polymorphism barcoding to evaluate oral cancer risk using odds ratio-based genetic algorithms. Kaohsiung J Med Sci 28: 362-368. doi:10.1016/j.kjms.2012.02.002. PubMed: 22726897.
26. Khlifi R, Rebai A, Hamza-Chaffai A, (2012) Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma. J Genet 91: 375-384. doi:10.1007/s12041-012-0193-z. PubMed: 23271025.
27. Mahjabeen I, Baig RM, Masood N, Sabir M, Inayat U, et al. (2012) Genetic Variations in XRCC1 Gene in Sporadic Head and Neck Cancer (HNC) Patients. Pathol Oncol Res, 19: 183-8. PubMed: 23055018.
28. Vaezi A, Feldman CH, Niedernhofer LJ, (2011) ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer. Pharmgenomics Pers Med 4: 47-63.
29. Ruwali M, Khan AJ, Shah PP, Singh AP, Pant MC, et al. (2009) Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors. Environ Mol Mutagen 50: 473-482. doi:10.1002/em.20488. PubMed: 19334053.
30. Kumar A, Pant MC, Singh HS, Khandelwal S, (2012) Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India. Tumour Biol 33: 111-119. doi:10.1007/s13277-011-0253-7. PubMed: 22081374.
31. Majumder M, Sikdar N, Paul RR, Roy B, (2005) Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Cancer Epidemiol Biomarkers Prev 14: 2106-2112. doi:10.1158/1055-9965.EPI-05-0108. PubMed: 16172217.
32. Gugatschka M, Dehchamani D, Wascher TC, Friedrich G, Renner W, (2011) DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck. Exp Mol Pathol 91: 331-334. doi:10.1016/j.yexmp.2011.03.004. PubMed: 21419115.
33. Kowalski M, Przybylowska K, Rusin P, Olszewski J, Morawiec-Sztandera A, et al. (2009) Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res 28: 37. doi:10.1186/1756-9966-28-37. PubMed: 19284666.
34. Applebaum KM, McClean MD, Nelson HH, Marsit CJ, Christensen BC, et al. (2009) Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer 124: 2690-2696. doi:10.1002/ijc.24256. PubMed: 19230024.
35. Kietthubthew S, Sriplung H, Au WW, Ishida T, (2006) Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 209: 21-29. doi:10.1016/j.ijheh.2005.06.002. PubMed: 16373199.
36. Demokan S, Demir D, Suoglu Y, Kiyak E, Akar U, et al. (2005) Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol Oncol Res 11: 22-25. doi:10.1007/BF03032401. PubMed: 15800678.
37. Tae K, Lee HS, Park BJ, Park CW, Kim KR, et al. (2004) Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 111: 805-808. doi:10.1002/ijc.20338. PubMed: 15252855.
38. Varzim G, Monteiro E, Silva RA, Fernandes J, Lopes C, (2003) CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev 12: 495-499. doi:10.1097/00008469-200312000-00008. PubMed: 14639127.
39. Yuan H, Li H, Ma H, Niu Y, Wu Y, et al. (2012) Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population. Exp Ther Med 3: 719-724. PubMed: 22969958.
40. Kostrzewska-Poczekaj M, Gawe{ogonek}cki W, Illmer J, Rydzanicz M, Gajecka M, et al. (2013) Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol 270: 271-276. doi:10.1007/s00405-012-1993-8. PubMed: 22427030.
41. Al-Hadyan KS, Al-Harbi NM, Al-Qahtani SS, Alsbeih GA, (2012) Involvement of single-nucleotide polymorphisms in predisposition to head and neck cancer in Saudi Arabia. Genet Tests Mol Biomarkers 16: 95-101. doi:10.1089/gtmb.2011.0126. PubMed: 21877955.
42. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, et al. (2010) Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet 51: 343-352. doi:10.1007/BF03208865. PubMed: 20720310.
43. Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, et al. (2008) Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 71: 887-897. doi:10.1080/15287390801988160. PubMed: 18569591.
44. Li C, Hu Z, Lu J, Liu Z, Wang LE, et al. (2007) Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer 110: 867-875. doi:10.1002/cncr.22861. PubMed: 17614107.
45. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, et al. (1999) Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129. doi:10.1093/carcin/20.11.2125. PubMed: 10545415.
46. Dos Reis MB, Losi-Guembarovski R, de Souza Fonseca Ribeiro EM, Cavalli IJ, Morita MC, et al. (2013) Allelic variants of XRCC1 and XRCC3 repair genes and susceptibility of oral cancer in Brazilian patients. J Oral Pathol Med 42: 180-185.
47. Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, et al. (2008) Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 37: 271-277. PubMed: 18410587.
48. Majumder M, Sikdar N, Ghosh S, Roy B, (2007) Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 120: 2148-2156. doi:10.1002/ijc.22547. PubMed: 17290401.
49. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27: 997-1007. doi:10.1093/carcin/bgi280. PubMed: 16308313.
50. Rydzanicz M, Wierzbicka M, Gajecka M, Szyfter W, Szyfter K, (2005) The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck. Cancer Lett 224: 263-278. doi:10.1016/j.canlet.2005.01.015. PubMed: 15914277.
51. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Wierzbicka M, Szyfter W, et al. (2005) Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic results. Adv Otorhinolaryngol 62: 25-37. PubMed: 15608415.
52. Cao Y, Miao XP, Huang MY, Deng L, Hu LF, et al. (2006) Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 6: 167. doi:10.1186/1471-2407-6-167. PubMed: 16796765.
53. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, et al. (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 12: 1100-1104. PubMed: 14578150.
54. Yang ZH, Du B, Wei YS, Zhang JH, Zhou B, et al. (2007) Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol 26: 491-496. PubMed: 17630853.
55. Ho T, Li G, Lu J, Zhao C, Wei Q, et al. (2007) X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas. Cancer 110: 318-325. doi:10.1002/cncr.22794. PubMed: 17559126.
56. Silverman S Jr, Gorsky M, (1990) Epidemiologic and demographic update in oral cancer: California and national data--1973 to 1985. J Am Dent Assoc 120: 495-499. PubMed: 2335670.
57. Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, et al. (2009) The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med 219(1):: 43-51. PubMed: 19713684.